ATH686 is a potent, selective, ATP-competitive FLT3 kinase inhibitor used in research to study FLT3-mutant leukemia. It inhibits mutant FLT3 activity, induces apoptosis, and suppresses proliferation in FLT3-mutant cells.
- Potent, selective ATP-competitive FLT3 inhibition.
- Demonstrated induction of apoptosis and cell-cycle arrest in FLT3-mutant cells.
- High purity suitable for biochemical and cellular assays.
- Available as solid and as 10 mM solution in DMSO for convenience.
- Stable under recommended storage conditions for long-term use.